Private Capital Advisors, Inc. Immunome Inc. Call Options Transaction History
Private Capital Advisors, Inc.
- $824 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMNM
# of Institutions
132Shares Held
50.7MCall Options Held
38.7KPut Options Held
2.34M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.5MShares$48.8 Million0.04% of portfolio
-
Redmile Group, LLC San Francisco, CA4.83MShares$42.8 Million3.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$38.2 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$34.4 Million1.86% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$33.3 Million0.0% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $108M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...